Dexamethasone-Integrated Mesenchymal Stem Cells for Systemic Lupus Erythematosus Treatment via Multiple Immunomodulatory Mechanisms

Scientists presented a promising strategy based on dexamethasone liposome-integrated MSCs for treating systemic lupus erythematosus via multiple immunomodulatory pathways.